SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950142-02-000493
Filing Date
2002-05-20
Accepted
2002-05-20 16:35:04
Documents
7
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS EC, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.PERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM AH, INC.SFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d-bioenvision.txt SC 13D 67722
3 EXHIBIT 1 ex1sc13d-bioenvision.txt EX-99 4932
4 EXHIBIT 2 ex2sc13d-bioenvision.txt EX-10 101567
5 EXHIBIT 3 ex3sc13d-bioenvision.txt EX-10 60132
6 EXHIBIT 4 ex4sc13d-bioenvision.txt EX-4 51425
7 EXHIBIT 5 ex5sc13d-bioenvision.txt EX-10 68187
8 EXHIBIT 6 ex6sc13d-bioenvision.txt EX-24 2665
  Complete submission text file 0000950142-02-000493.txt   359861
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address ONE ROCKEFELLER PLAZA SUITE 1600 NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA SUITE 1600 NEW YORK NY 10020 2124456581
BIOENVISION INC (Subject) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-78274 | Film No.: 02657873
SIC: 2834 Pharmaceutical Preparations